These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 17552953)

  • 1. Comparison of a 3-day with a 1-day regimen of an extended-release formulation of ciprofloxacin as antimicrobial prophylaxis for patients undergoing transrectal needle biopsy of the prostate.
    Schaeffer AJ; Montorsi F; Scattoni V; Perroncel R; Song J; Haverstock DC; Pertel PE
    BJU Int; 2007 Jul; 100(1):51-7. PubMed ID: 17552953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective assessment of the efficacy of single dose versus traditional 3-day antimicrobial prophylaxis in 12-core transrectal prostate biopsy.
    Cam K; Kayikci A; Akman Y; Erol A
    Int J Urol; 2008 Oct; 15(11):997-1001. PubMed ID: 18721198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-dose antibiotic prophylaxis in core prostate biopsy: Impact of timing and identification of risk factors.
    Lindstedt S; Lindström U; Ljunggren E; Wullt B; Grabe M
    Eur Urol; 2006 Oct; 50(4):832-7. PubMed ID: 16750292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One preoperative dose randomized against 3-day antibiotic prophylaxis for transrectal ultrasonography-guided prostate biopsy.
    Briffaux R; Coloby P; Bruyere F; Ouaki F; Pires C; Doré B; Irani J
    BJU Int; 2009 Apr; 103(8):1069-73; discussion 1073. PubMed ID: 19021604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of antibiotic prophylaxis for transrectal prostate biopsy].
    Yang L; Hu J; Wei H; Wang L; Zhong H
    Zhonghua Wai Ke Za Zhi; 2001 Dec; 39(12):940-2. PubMed ID: 16201177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Short or long schemes of antibiotic prophylaxis for prostate biopsy. A multicentre prospective randomised study].
    Briffaux R; Merlet B; Normand G; Coloby P; Leremboure H; Bruyère F; Pires C; Ouaki F; Doré B; Irani J
    Prog Urol; 2009 Jan; 19(1):39-46. PubMed ID: 19135641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate needle biopsy infection after four or six dose ciprofloxacin.
    Janoff DM; Skarecky DW; McLaren CE; Ahlering TE
    Can J Urol; 2000 Aug; 7(4):1066-9. PubMed ID: 11109076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
    Metallidis S; Kollaras P; Giannakakis T; Seitanidis B; Kordosis T; Nikolaidis J; Hatzitolios A; Nikolaidis P
    Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
    Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 'gap' between physician and patient assessment of symptom severity in acute cystitis?: a multicenter trial of women treated with extended-release ciprofloxacin.
    Tucker MK; Brigio FD; Sirotenko GA; Keating KN; Perfetto EM; Wilson K; Song J; Colgan R
    Postgrad Med; 2004 Dec; 116(6 Suppl Treating):11-20. PubMed ID: 19667683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy.
    Kapoor DA; Klimberg IW; Malek GH; Wegenke JD; Cox CE; Patterson AL; Graham E; Echols RM; Whalen E; Kowalsky SF
    Urology; 1998 Oct; 52(4):552-8. PubMed ID: 9763070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter study of single-dose and multiple-dose fleroxacin versus ciprofloxacin in the treatment of uncomplicated urinary tract infections.
    Iravani A
    Am J Med; 1993 Mar; 94(3A):89S-96S. PubMed ID: 8452189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic prophylaxis for transrectal prostate biopsy: a comparison of one-day and five-day regimen.
    Agbugui JO; Obarisiagbon EO; Osaigbovo EO; Osime CO; Akumabor PN
    Niger Postgrad Med J; 2014 Sep; 21(3):213-7. PubMed ID: 25331236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended-release ciprofloxacin (Cipro XR) for treatment of urinary tract infections.
    Talan DA; Naber KG; Palou J; Elkharrat D
    Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S54-66. PubMed ID: 15037329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective, randomized, multicentric, open, comparative study on the efficacy of a prophylactic single dose of 500 mg levofloxacin versus 1920 mg trimethoprim/sulfamethoxazole versus a control group in patients undergoing TUR of the prostate.
    Wagenlehner FM; Wagenlehner C; Schinzel S; Naber KG;
    Eur Urol; 2005 Apr; 47(4):549-56. PubMed ID: 15774257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy.
    Ozden E; Bostanci Y; Yakupoglu KY; Akdeniz E; Yilmaz AF; Tulek N; Sarikaya S
    Urology; 2009 Jul; 74(1):119-23. PubMed ID: 19464043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does disposable needle guide minimize infectious complications after transrectal prostate needle biopsy?
    Tuncel A; Aslan Y; Sezgin T; Aydin O; Tekdogan U; Atan A
    Urology; 2008 Jun; 71(6):1024-7; discussion 1027-8. PubMed ID: 18400273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-daily fleroxacin versus twice-daily ciprofloxacin in the treatment of complicated urinary tract infections.
    Frankenschmidt A; Naber KG; Bischoff W; Kullmann K
    J Urol; 1997 Oct; 158(4):1494-9. PubMed ID: 9302150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the concentration of ciprofloxacin in prostate tissue following administration of a single, 1000 mg, extended-release dose.
    Lugg J; Lettieri J; Stass H; Agarwal V
    J Chemother; 2008 Apr; 20(2):213-8. PubMed ID: 18467248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel pharmacokinetic-pharmacodynamic model for prediction of outcomes with an extended-release formulation of ciprofloxacin.
    Meagher AK; Forrest A; Dalhoff A; Stass H; Schentag JJ
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2061-8. PubMed ID: 15155200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.